HB Wealth Management LLC Makes New $261,000 Investment in HealthEquity, Inc. (NASDAQ:HQY)

HB Wealth Management LLC purchased a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 2,717 shares of the company's stock, valued at approximately $261,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wasatch Advisors LP raised its holdings in HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock valued at $635,065,000 after acquiring an additional 483,269 shares during the last quarter. Mackenzie Financial Corp increased its stake in HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company's stock valued at $203,822,000 after purchasing an additional 325,906 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its stake in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Barclays PLC lifted its position in HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after buying an additional 112,667 shares during the period. Finally, Thrivent Financial for Lutherans boosted its stake in HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company's stock worth $24,033,000 after buying an additional 73,404 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Stock Up 2.1 %

HQY stock traded up $2.17 during trading on Friday, reaching $106.88. The stock had a trading volume of 654,597 shares, compared to its average volume of 607,718. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a fifty day moving average price of $99.60 and a 200 day moving average price of $87.39. The company has a market capitalization of $9.26 billion, a P/E ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $107.87.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm posted $0.40 earnings per share. On average, equities analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HQY. JMP Securities boosted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research note on Tuesday, December 10th. The Goldman Sachs Group assumed coverage on HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 price target for the company. Royal Bank of Canada raised their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price for the company. Finally, Barrington Research raised their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, HealthEquity has a consensus rating of "Moderate Buy" and a consensus target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.